AIM ImmunoTech Q1 2026 Earnings EPS Miss Widens as Clinical Pipeline Drives Higher Operating Costs MXL Q1 2026 Earnings EPS Beats Estimates by Over 22 Yet Shares Decline INFU Q1 2026 Earnings Strong EPS Beat Offsets Cautious Market Sentiment AAON Q1 2026 Earnings EPS Surges Past Estimates with 62 Beat Pulmatrix Q2 2025 Earnings Loss Per Share Widens Amidst No Revenue Disclosure UAA Q1 2026 Earnings EPS Miss Amid Strategic Restructuring Progress